Iontophoretic transdermal delivery of ketoprofen: Novel method for the evaluation of plasma drug concentration in cutaneous vein

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 5, 2000, Pages 632-636

  Tashiro, Yoshikazu ^a   Kato, Yasuki ^a   Hayakawa, Eiji ^a   Ito, Kunio ^a,b  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b Janssen Pharmaceutical KK   (Japan)

Author keywords

Cutaneous vein; Iontophoresis; Ketoprofen; Plasma concentration; Transdermal delivery

Indexed keywords

KETOPROFEN;

ANIMAL TISSUE; ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TRANSPORT; IONTOPHORESIS; MALE; NONHUMAN; RAT; SKIN ABSORPTION; SKIN BLOOD FLOW; SKIN BLOOD VESSEL;

EID: 0034074234     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.632     Document Type: Article

References (24)

1. Singh P., Maibach H., Clin. Pharmacokinet., 26, 327-334 (1994).
2. Green P. G., J. Cont. Rel., 41, 33-48 (1996).
3. Roberts M. S., Lai P. M., Cross S. E., Yoshida N. H., "Mechanisms of Transdermal Drug Delivery," ed. by Potts R. O., Guy R. H., Marcel Dekker, New York, Basel, Hong Kong, 1997, pp. 291-349.
4. Cleary G. W., "Topical Drug Bioavailability, Bioequivalence, and Penetration," ed. by Shah V. P., Maibach H. I., Plenum Press, New York, London, 1993, pp. 17-68.
5. Gupta S. K., Bashaw E. D., Hwang S. S., "Topical Drug Bioavailability, Bioequivalence, and Penetration," ed. by Shah V. P., Maibach H. I., Plenum Press, New York, London, 1993, pp. 311-332.
6. Guy R. H., Hadgraft J., "Percutaneous Absorption, Mechanisms-Methodology-Drug Delivery," 2nd ed., ed. by Bronaugh R. L., Maibach H. I., Marcel Dekker, New York, Basel, 1989, pp. 13-26.
7. Siddiqui O., Roberts M. S., Polack E., J. Pharmaco. Biopharm., 17, 405-424 (1989).
8. Singh P., Roberts M. S., J. Pharm. Sci., 82, 873-879 (1993).
9. Singh P., Roberts M. S., J. Pharm. Sci., 83, 774-782 (1993).
10. Singh P., Roberts M. S., J. Pharm. Sci., 83, 783-791 (1994).
11. Singh P., Roberts M. S., J. Pharmacol. Exp. Ther., 268, 144-151 (1994).
12. Cross S. E., Roberts M. S., J. Pharm. Sci., 84, 584-592 (1995).
13. Singh P., Roberts M. S., J. Pharmacol. Exp. Ther., 279, 908-917 (1996).
14. Gao X., Wientjes M. G., Au J. L.-S., Pharm. Res., 14, 2012-2017 (1995).
15. Wojciechowski Z., Pershing L. K., Huether S., Leonard L., Burton S. A., Higuchi W. I., Krueger G. G., J. Invest. Dermatol., 88, 439-446 (1987).
16. Pershing L. K., Huether S., Conklin R. L., Krueger G. G., J. Invest. Dermatol., 92, 355-359 (1989).
17. Pershing L. K., Krueger G. G., "Percutaneous Absorption, Mechanisms-Methodology-Drug Delivery," 2nd ed., ed. by Bronaugh R. L., Maibach H. I., Marcel Dekker, New York, Basel, 1989, pp. 397-414.
18. Cook M. J. (ed.), "The Anatomy of the Laboratory Mouse," Academic Press, London, New York, 1965, p. 110.
19. Ballerini R., Casini A., Chinol M., Mannucci C., Giaccai L., Salvi M., Int. J. Clin. Pharm. Res., 6, 69-72 (1986).
20. Nishihara K. K., Furst D. E., "Arthritis and Allied Conditions, A Textbook of Rheumatology, Vol. 1," 13th ed., ed. by Koopman W. J., Williams & Wilkins, Baltimore, 1996, pp. 611-654.
21. Avouac B., Teule M., J. Clin. Pharmacol., 28, S2-S7 (1988).
22. Radermacher J., Jentsch D., Scholl M. A., Lustinetz T., Frolich J. C., Br. J. Clin. Pharmac., 31, 537-541 (1991).
23. Glass J. M., Stephen R. L., Jacobson S. C., Int. J. Dermatol., 19, 519-525 (1980).
24. Franz T. J., Tojo K., Shah K. R., Kydonieus A., "Treatise on Controlled Drug Delivery, Fundamentals-Optimization-Application," ed. by Kydonieus A., Marcel Dekker, New York, Basel, Hong Kong, 1992, pp. 341-421.